Shiwei Cui Selected Research

isophane insulin lispro drug combination (25:75) insulin lispro

1/2020

Effects of Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiwei Cui Research Topics

Disease

12	Insulin Resistance 09/2021 - 02/2015
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2010
2	Premature Birth (Birth, Premature) 05/2022 - 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Diabetes Mellitus 01/2021
1	Lung Diseases (Lung Disease) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Lung Injury 01/2020
1	Dyslipidemias (Dyslipidemia) 10/2016
1	Rhabdomyolysis 10/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2016
1	Inflammation (Inflammations) 12/2015
1	Hypoxia (Hypoxemia) 07/2015

Drug/Important Bio-Agent (IBA)

8	PalmitatesIBA 10/2017 - 02/2015
5	Insulin (Novolin)FDA Link 01/2021 - 07/2015
3	Blood Glucose (Blood Sugar)IBA 09/2021 - 11/2018
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017 - 07/2015
2	DNA AdductsIBA 05/2022 - 01/2022
2	Benzo(a)pyreneIBA 05/2022 - 01/2022
2	Carotenoids (Carotene)IBA 05/2022 - 01/2022
2	Folic Acid (Vitamin M)FDA LinkGeneric 05/2022 - 01/2022
2	VitaminsIBA 05/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 11/2018
2	Exenatide (Byetta)FDA Link 09/2021 - 01/2020
2	AutoantibodiesIBA 01/2021 - 09/2016
2	Glycogen Synthase KinasesIBA 01/2017 - 07/2015
2	Nonesterified Fatty Acids (NEFA)IBA 07/2015 - 02/2015
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021
1	oxidized low density lipoproteinIBA 01/2021
1	islet cell antibodyIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	fibroblast growth factor 21IBA 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	gallium arsenide (GaAs)IBA 01/2020
1	isophane insulin lispro drug combination (25:75) insulin lisproIBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2018
1	Indicators and Reagents (Reagents)IBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	C-terminal binding proteinIBA 01/2017
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016
1	Fenofibrate (CiL)FDA LinkGeneric 10/2016
1	Phosphotransferases (Kinase)IBA 12/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015
1	Karyopherins (Importin)IBA 12/2015
1	Small Interfering RNA (siRNA)IBA 12/2015
1	TNF Receptor-Associated Factor 1IBA 11/2015
1	Glycogen Synthase (Synthase I)IBA 10/2015
1	p38 Mitogen-Activated Protein KinasesIBA 10/2015
1	Insulin Receptor Substrate ProteinsIBA 09/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015
1	LipidsIBA 09/2015
1	Insulin ReceptorIBA 09/2015
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 09/2015
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2015

Therapy/Procedure

2	Therapeutics 09/2021 - 10/2016
1	Glycemic Control 05/2010